Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer

BACKGROUND: Breast cancer (BC) is the most common cancer in women, and despite the introduction of new screening programmes, therapies and monitoring technologies, there is still a need to develop more useful tests for monitoring treatment response and to inform clinical decision making. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez-Garcia, Daniel, Hills, Allison, Page, Karen, Hastings, Robert K., Toghill, Bradley, Goddard, Kate S., Ion, Charlotte, Ogle, Olivia, Boydell, Anna Rita, Gleason, Kelly, Rutherford, Mark, Lim, Adrian, Guttery, David S., Coombes, R. Charles, Shaw, Jacqueline A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924016/
https://www.ncbi.nlm.nih.gov/pubmed/31856868
http://dx.doi.org/10.1186/s13058-019-1235-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924016/
https://www.ncbi.nlm.nih.gov/pubmed/31856868
http://dx.doi.org/10.1186/s13058-019-1235-8

Ejemplares similares